Fermenta Biotech has informed that pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, the weblink of the audio recording of Earnings conference call held on Wednesday, June 1, 2022, to discuss the financial performance of the Company for the quarter and financial year ended March 31, 2022 is as below - https://www.mediafire.com/file/jdrfyhakb6qo3sv/Concall-FermantaBiotech-01062022.mp3/file The same audio recording is also available on Company's website at www.fermentabiotech.com This information is submitted to you pursuant to Regulation 30 and 46 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1627.90 |
| Dr. Reddys Lab | 1308.20 |
| Cipla | 1289.50 |
| Zydus Lifesciences | 924.00 |
| Lupin | 2305.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: